Back to Authors

Januario, Thomas

A5028113296 | I2802871645

Mayo Clinic

Department of Molecular Diagnostics and Cancer Cell Biology, Genentech Inc., South San Francisco, CA 94080, USA

Citations 1

CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma

Science Translational Medicine | March 16, 2011 | Volume: 3 | Issue: 74 | Pages: No page available

10.1126/scitranslmed.3001620 | PMID 21411738

A 15-gene expression signature predicts whether a patient with diffuse large B cell lymphoma will respond to dacetuzumab, a therapeutic antibody.